Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15628682 | 0.97 | TSHR (0.38) | TSHRLMNATDP1CNR1ADRA1A | |
| SCHEMBL13877207 | 0.97 | TSHR (0.38) | TSHRLMNATDP1CNR1ADRA1A | |
| SCHEMBL8529610 | 0.90 | TSHR (0.38) | TSHRLMNATDP1CNR1ADRA1A | |
| SCHEMBL10486462 | 0.87 | TSHR (0.32) | TSHR | |
| SCHEMBL24094055 | 0.85 | — | — | |
| SCHEMBL224194 | 0.85 | — | — | |
| SCHEMBL10100320 | 0.85 | — | — | |
| SCHEMBL15810584 | 0.83 | TSHR (0.60) | TSHRLMNATDP1 | |
| SCHEMBL10100324 | 0.83 | TSHR (0.33) | TSHRTDP1 | |
| SCHEMBL223185 | 0.83 | TSHR (0.33) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108949104-B | Anti-seepage composition and using method | 王鹏 | 2021-06-25 | — | — | CN | disclosed |
| US-10759966-B1 | Optical laminate and flexible display apparatus comprising the same | LG CHEM, LTD. (KR) | 2020-09-01 | — | — | US | disclosed |
| US-20180030207-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-02-01 | — | — | US | disclosed |
| US-20170049903-A1 | COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-02-23 | — | — | US | disclosed |
| WO-2015130890-A9 | SYNTHETIC SALT COMPLEXES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-29 | — | — | WO | disclosed |
| WO-2015134256-A1 | COMBINATORIAL LIBRARIES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-11 | — | — | WO | disclosed |
| WO-2015130893-A1 | SYNTHETIC OLIGOGLUCOSAMINES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-03 | — | — | WO | disclosed |
| WO-2015130890-A1 | SYNTHETIC SALT COMPLEXES FOR IMPROVEMENT OF PLANT GROWTH AND YIELD | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-03 | — | — | WO | disclosed |
| US-20150203634-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2015-07-23 | — | — | US | disclosed |
| US-20150050233-A1 | COMPOSITIONS CONTAINING INCLUSION COMPLEXES | CALANDO PHARMACEUTICALS, INC. (US) | 2015-02-19 | — | — | US | disclosed |
| US-7018609-B2 | Compositions containing inclusion complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2006-03-28 | — | — | US | disclosed |
| US-6884789-B2 | Linear cyclodextrin copolymers | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-04-26 | — | — | US | disclosed |
| EP-1351710-A2 | COMPOSITIONS CONTAINING INCLUSION COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-15 | — | — | EP | disclosed |
| US-20030017972-A1 | Complexing agents for compositions containing inclusion complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY AND INSERT THERAPEUTICS, INC | 2003-01-23 | — | — | US | disclosed |
| US-6509323-B1 | Cyclodextrin copolymers may be used as a delivery vehicle of various therapeutic agents | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-01-21 | — | — | US | disclosed |
| US-20030008818-A1 | Compositions containing inclusion complexes | CALIFORNIA INSTITUTE OF TECHNOLOGY AND INSERT THERAPEUTICS, INC | 2003-01-09 | — | — | US | disclosed |
| US-20020151523-A1 | Linear cyclodextrin copolymers | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-10-17 | — | — | US | disclosed |
| WO-2002049676-A2 | COMPOSITIONS CONTAINING INCLUSION COMPLEXES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-06-27 | — | — | WO | disclosed |
| EP-1133318-A1 | SUPRAMOLECULAR COMPLEXES CONTAINING THERAPEUTIC AGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000033885-A1 | SUPRAMOLECULAR COMPLEXES CONTAINING THERAPEUTIC AGENTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008818-A1 | Compositions containing inclusion complexes | EXOSC5, EXOSC9, INTS6 | TSHR 4512/4885LMNA 1461/4885TDP1 1502/4885 |
| US-20180030207-A1 | LINEAR CYCLODEXTRIN COPOLYMERS | DDOST, SI, PDIA6 | TSHR 4451/4885LMNA 3425/4885TDP1 2773/4885 |
| US-20030017972-A1 | Complexing agents for compositions containing inclusion complexes | INTS6, EXOSC5, PCBP1 | TSHR 4563/4885LMNA 1644/4885TDP1 1686/4885 |
| US-20150050233-A1 | COMPOSITIONS CONTAINING INCLUSION COMPLEXES | EXOSC5, EXOSC9, INTS6 | TSHR 4519/4885LMNA 1441/4885TDP1 1685/4885 |
| US-20020151523-A1 | Linear cyclodextrin copolymers | DDOST, SI, PDIA6 | TSHR 4451/4885LMNA 3425/4885TDP1 2773/4885 |
| US-20170049903-A1 | COMPLEXING AGENTS FOR COMPOSITIONS CONTAINING INCLUSION COMPLEXES | INTS6, EXOSC5, PCBP1 | TSHR 4564/4885LMNA 1557/4885TDP1 2002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.